Impact of Respiratory Viral Panel Polymerase Chain Reaction Assay Turnaround Time on Length of Stay and Antibiotic Use in Patients With Respiratory Viral Illnesses
Authors:
- 10 October 2017
- journal article
- research article
- Published by SAGE Publications in Hospital Pharmacy
- Vol. 52 (9) , 640-644
Abstract
Background: Respiratory viral illnesses account for many hospitalizations and inappropriate antibiotic use. Respiratory viral panels by polymerase chain reaction (RVP-PCR) provide a reliable means of diagnosis. In 2015, the RVP-PCR assay at our institution was switched from respiratory viral panel (RVP) to rapid respiratory panel (rapid RP), which has a faster turnaround time (24 hours vs 12 hours, respectively). The purpose of this study was to evaluate the effect of RVP-PCR tests on duration of antibiotic use and length of stay (LOS) in hospitalized patients. Methods: We performed a retrospective chart review of patients who had a RVP-PCR ordered within a 1-year time period before and after the assay switch. Patients who were pregnant, had received antibiotics within 30 days prior to admission, were not discharged, or had not completed antibiotics by end of study period were excluded. Results: Data were obtained from a total of 140 patients (70 in each group). Of these, 25 (35.7%) in the RVP group and 28 (40.0%) in the rapid RP group had a positive result. The median LOS was 4.5 days (IQR, 3-9 days) in the RVP group and 5 days (IQR, 3-9 days) in the rapid RP group (P = .78). The median duration of antibiotic use was 4 days (IQR, 2-7 days) in the RVP group and 5 days (IQR, 1-7 days) in the rapid RP group (P = .8). Conclusion: Despite faster turnaround time, there was no significant difference in duration of antibiotic use, or LOS between the RVP and rapid RP groups.Keywords
This publication has 7 references indexed in Scilit:
- Utilization of Viral Molecular Diagnostics Among Children Hospitalized With Community Acquired PneumoniaHospital Pediatrics, 2014
- Comparison of the Biofire FilmArray RP, Genmark eSensor RVP, Luminex xTAG RVPv1, and Luminex xTAG RVP Fast Multiplex Assays for Detection of Respiratory VirusesJournal of Clinical Microbiology, 2013
- Role of a Respiratory Viral Panel in the Clinical Management of Pediatric InpatientsThe Pediatric Infectious Disease Journal, 2013
- Comparison of the Luminex xTAG RVP Fast Assay and the Idaho Technology FilmArray RP Assay for Detection of Respiratory Viruses in Pediatric Patients at a Cancer HospitalJournal of Clinical Microbiology, 2012
- The Diagnosis of Viral Respiratory Disease in Older AdultsClinical Infectious Diseases, 2010
- Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and ImmunologyClinical Microbiology Reviews, 2010
- Cost-effectiveness of rapid diagnosis of viral respiratory tract infections in pediatric patientsJournal of Clinical Microbiology, 1997